Walleye Capital’s OptiNose OPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,415
Closed -$133K 3448
2022
Q2
$133K Buy
+2,415
New +$88.8K ﹤0.01% 1664
2021
Q2
Sell
-18,191
Closed -$1.01K 1464
2021
Q1
$1.01K Buy
18,191
+1,035
+6% +$63K 0.06% 298
2020
Q4
$1.06K Sell
17,156
-2,844
-14% -$174K 0.07% 273
2020
Q3
$1.17M Buy
+20,000
New +$1.48M 0.13% 213

Other funds holding OPTN

Walleye Capital's OPTN Position: Q3 2022 in Review

Walleye Capital sold out of OptiNose (OPTN) in Q3 2022, closing a stake of 2,415 shares — an estimated $133K sold.

Walleye Capital first reported a position in OPTN in Q3 2020 and held it in 4 quarters. The position peaked at $1.17M in Q3 2020. 50 funds tracked by Wall St. Rank hold OPTN as of Q3 2022.

  • Walleye Capital reported no remaining OptiNose position as of Q3 2022 after selling out during the quarter.
  • Walleye Capital sold 2,415 OptiNose shares in Q3 2022, an estimated $133K.
  • Walleye Capital first reported a position in OptiNose in Q3 2020 and held it in 4 quarters.
  • Walleye Capital's OptiNose position peaked at $1.17M in Q3 2020.
  • 50 funds tracked by Wall St. Rank held OptiNose as of Q3 2022.

Based on Walleye Capital's 13F filing for Q3 2022, filed 14 Nov 2022.